MEDTE:PA:PA-BNP Paribas Easy ECPI Global ESG Med Tech UCITS ETF EUR Capitalisation (EUR)

ETF | Others |

Last Closing

USD 8.7966

Change

-0.08 (-0.90)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.03 (+0.06%)

USD 66.12B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+3.00 (+0.60%)

USD 10.74B
WRD:PA HSBC ETFs Public Limited Compa..

+0.09 (+0.28%)

USD 9.02B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-2.45 (-1.02%)

USD 7.57B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+3.50 (+0.79%)

USD 6.92B
HHH:PA HSBC ETFs Public Limited Compa..

+0.30 (+0.59%)

USD 6.65B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.93 (+0.29%)

USD 6.26B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.05 (+0.30%)

USD 5.24B
500U:PA Amundi Index Solutions - Amund..

+0.02 (+0.02%)

USD 4.58B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+1.07 (+0.74%)

USD 3.86B

ETFs Containing MEDTE:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.50% 36% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.50% 38% F 50% F
Trailing 12 Months  
Capital Gain 2.09% 18% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.09% 53% F 69% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.41% 24% F 35% F
Dividend Return 0.41% 23% F 34% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1.85% 96% N/A 98% N/A
Risk Adjusted Return 22.30% 35% F 46% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.